Get to know the investigational new drug application (IND). This includes the types, laws and regulations, and emergency use of INDs.
Similar Posts
FDA In Brief: FDA issues 57 product-specific guidances, including 19 laying out path for developing generics to hard-to-copy “complex” medicines
FDA is posting 57 product-specific guidances to help industry generate evidence needed to support approval of generic drug applicationsMAMTAKIM Inc Recalls Dried Whole Smelts Salted (KORUSHKA) Because of Possible Health Risk
MAMTAKIM Inc, located at 888 Magnolia Ave, Elizabeth, NJ 07201, is recalling Item # LL0320 DRIED WHOLE SMELTS SALTED (KORUSHKA), 5.29 oz (150 g) / 20 – 1 box, because this product consists of dried, un eviscerated fish longer than 5 inches, which has the potential to be contaminated with ClostridiumResponding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection
Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP InspectionExamples of Accepted Emerging Technologies
CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.OTC Monograph Reform: OTC Sunscreen Drugs – 12/15/2021
Webinar to discuss the deemed final order (DFO) for over-the-counter (OTC) sunscreen drugs and proposed order for OTC sunscreen drugsFrequently Asked Questions about Drug Shortages
This page answers frequently asked questions (FAQ) about drug shortages such as what is a drug shortage, how many per year, how the FDA addresses and takes action on shortages, how the FDA notifies the public, what manufacturers are supposed to report to the FDA, and reasons for many drug shortages